6.200 -0.040 (-0.64%) 05-03 17:36 |
|
Open: | 6.240 |
High: | 6.480 |
Low: | 6.080 |
Pre. close: | 6.240 |
Volume: | 222,290 |
Avg. volume: | 155,216 |
MA (50): | 4.866 |
MA (200): | 4.164 |
Year high: | 7.310 |
Year low: | 2.705 |
Market cap: | 121(M) |
EPS: | -1.18 |
PE ratio: | -5.25 |
SELL | BUY |
HeikinAshi: | |
Kaufmans AMA: | |
Chandelier (20): | |
MA (5): | |
MA (50): | |
MACD (26,12,9): | |
Slow KDJ (14,3): | |
RSI (14): | |
CCI (20): |
Tue, 16 Apr 2024
OSE Immunotherapeutics' Global License to Develop a Novel - GlobeNewswire
Tue, 02 Apr 2024
OSE Immunotherapeutics Announces Peer-Reviewed Publication on Novel Myeloid Immune Checkpoint CLEC-1 in ... - GlobeNewswire
Wed, 06 Mar 2024
AbbVie Partners with OSE Immunotherapeutics on Novel mAb for Chronic Inflammation - Pharmaceutical Technology Magazine
Wed, 28 Feb 2024
OSE Immunotherapeutics to Host a Live Webcast to Discuss AbbVie Global Partnership - Business Wire
Wed, 28 Feb 2024
AbbVie licenses OSE's chronic inflammation therapy for $48m upfront - Pharmaceutical Technology
Wed, 28 Feb 2024
AbbVie and OSE Immunotherapeutics Announce Partnership to Develop a Novel Monoclonal Antibody for the ... - PR Newswire
©NovaStocks.com | euro Stocks quote, company news, stock charts, technical analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither NovaStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: Financial Modeling Prep
Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Third parties' use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.